Susquehanna International Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $68.8K | Sell |
|
|||||
|
2025
Q2 | $172K | Sell |
|
|||||
|
2025
Q1 | $2.11M | Buy |
|
|||||
|
2024
Q4 | $196K | Buy |
|
|||||
|
2024
Q3 | $71.8K | Sell |
|
|||||
|
2024
Q2 | $227K | Buy |
|
|||||
|
2024
Q1 | $153K | Sell |
|
|||||
|
2023
Q4 | $161K | Buy |
|
|||||
|
2023
Q3 | $848K | Buy |
|
|||||
|
2023
Q2 | $208K | Sell |
|
|||||
|
2023
Q1 | $230K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $355K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $502K | Buy |
|
|||||
|
2021
Q4 | $344K | Buy |
|
|||||
|
2021
Q3 | $236K | Sell |
|
|||||
|
2021
Q2 | $1.25M | Sell |
|
|||||
|
2021
Q1 | $11.3M | Buy |
|
|||||
|
2020
Q4 | $715K | Buy |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $58K | Buy |
|
|||||
|
2019
Q3 | $31K | Sell |
|
|||||
|
2019
Q2 | $155K | Buy |
|
|||||
|
2019
Q1 | $90K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $460K | Buy |
|
|||||
|
2018
Q1 | $222K | Sell |
|
|||||
|
2017
Q4 | $1.8M | Buy |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1.01M | Buy |
|